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Abstract: Aim: To develop and validate a procedure for self-management of medication by patients
whilst in hospital. Background: Self-management of medication allows patients to self-manage
their medication in a controlled and supportive hospital environment. This practice is encouraged
worldwide, yet an evidence-based procedure to evaluate the ability of patients to self-manage and
to monitor and support self-management are absent. Methods: The evidence-based procedure for
self-management of medication (SelfMED) was developed based on previous conducted qualitative
research, literature review, and the current regulation. It was validated by healthcare providers and a
multidisciplinary expert meeting. Questions within the procedure that could be biased were tested for
inter-rater reliability. Results: First, the SelfMED procedure was developed. It consists of a stepped
assessment of patient’s competencies for self-management performed by healthcare providers and the
patient. When self-management is allowed, the SelfMED monitoring tool monitors the patient’s intake
of self-managed medication. Secondly, the procedure was revised for clarity, appropriateness, and
face validity by five healthcare providers and a multidisciplinary expert meeting, resulting in the final
version. Thirdly, three questions from the final version were tested for interrater reliability. Cohen’s
Kappa showed moderate to strong levels of agreement. Conclusions: The developed SelfMED
procedure provides an evidence based approach of facilitating self-management of medication. The
content of the procedure was found valid to evaluate the patient’s ability to self-manage and to
monitor them while self-managing.
Keywords: hospital medicine; medication management; medication self-management; inpatients
1. Introduction
Patients self-administering their medication while hospitalized has been mentioned in literature
as far back as 1959 [1]. Previous research established self-administration of medication has been
implemented in acute hospitals in the United Kingdom. Nevertheless, the levels of implementation
remained variable [2,3]. The Society of Hospital Pharmacists of Australia, described self-management
as a strategy to evaluate the medication management of hospitalized patients in order to prevent
medication related problems after discharge. Facilitating self-administration in a supervised setting
and combined with support could result in confident and competent patients. The Society describes
self-administration in hospitals as an important contribution to a return to independent living at home
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after discharge [4]. Belgian research on the actual prevalence showed 22% of hospitalized patients
did self-administer medication. Concerning the opinion of nurses on the ability of these hospitalized
patients to prepare and administer medication by themselves, just 40.9% of the patients were deemed
able to do so. The decision of allowing self-administration was mostly a shared process between
patients and healthcare providers. In 28.3% the patient, nurse, and treating physician were involved
and in 26.3% the nurse and the patient [5]. Overall, it is possible to conclude self-management is not
an unusual practice and it has been studied and implemented worldwide [4,6–8].
Although, self-administration of medication is implemented in practice, a rigorous study
on 56 Flemish nonacute hospital wards showed some clear shortcomings. Only 17.9% of the
included wards had a procedure for self-administration of medication and 7.1% of the wards
had a screening tool to assess patients on their self-management ability before allowing them to
self-administer [5]. A qualitative study on the perspectives of healthcare providers and patients
concerning self-administration of medication during hospitalization acknowledged these findings.
The interviewed respondents indicated it is not clear how to identify whether a patient is able to
self-administer medication or not. Also, healthcare providers and patients worried about how
to monitor self-administered medication correctly, as there was no guideline to support this act.
Respondents in this study were not up to date on the current legislation or regulation concerning
self-administration of medication and were very insecure on how to handle this in practice [9].
Self-administration of medication, as described in the literature, focuses on the actual
administration of medication. However, allowing self-administration of medication by patients whilst
in hospital requires adjustments in general medication management (i.e., preference for the use of unit
dose medication and providing patient education on self-administered medication). Therefore, the term
self-management of medication is preferred. This term includes both medication administration and
aspects of medication management such as monitoring self-administration, providing education
on self-administered medication by healthcare providers, and the support of every stakeholder in
the process in order to succeed in self-managing medication [5,6,9]. Two systematic reviews on
self-management of medication confirmed the presence of very diversely structured self-management
programs (SMP’s), with different contents. Although, several SMP’s have been designed in studies,
very little have been thoroughly validated and tested [6,7].
As previous research showed, a self-management of medication procedure should include an
assessment in order to define whether a patient is capable of self-managing medication. If a patient is
deemed capable, a monitoring tool should support self-management to be safe and all aspects on the
current regulation should be clear in order to adhere to [5,9].
A literature search on assessments in order to define whether a patient is capable of self-managing
medication identified two articles on the validation of a self-administration of medication (SAM)
screening tool in order to define the patient’s competencies. The SAM screening tool consisted of two
parts. The first part had to be answered by the patient and was filled in by an administrator. The
patient’s desire to self-manage was evaluated with the use of a visual analog scale. This scale questioned
the patient (1) whether he/she deems him/herself competent for managing regular medication
independently while in hospital and (2) how much he/she would like to manage these regular
medications while in hospital. Also, demographic data on the patient’s discharge destination and
responsibility for medication management following discharge was collected. The second part had
to be filled in by the nurses if the patient was willing to self-manage. It consisted of questions
on the patient’s capability to self-medicate (11 questions), knowledge of medications and behavior
(7 questions), and experience with self-medicating (6 questions). In the end, the nurse needed to make a
global assessment with the use of a visual analog scale, resulting in a maximum score of 96 points. The
cut-off was installed at 60, below this cut-off patients were not able to self-manage medication [8,10].
Specific literature concerning the validation of a monitoring tool to follow up self-administration are
still lacking, although the systematic review written by Wright et al. indicated nurses monitored the
Pharmacy 2018, 6, 77 3 of 11
intake of self-administered medication. Yet, monitoring in these studies was part of collecting the
outcome (adherence), not a way of observing and monitoring self-management [6,7].
Results from previously conducted research provided some evidence on the content of a procedure
for self-management of medication in hospitals. Nevertheless, they revealed some important
issues not included in the previous tools. First, there is a need for a multidisciplinary approach;
hospital pharmacists, physicians, nurses, and patients have their own responsibilities and should
therefore be included in the process of evaluating competencies for self-management [11]. Secondly,
this multidisciplinary approach should be included in a much-needed assessment which clarifies and
takes into account the current legal framework on self-management in hospitals. Thirdly, an instrument
for monitoring self-management should be provided within the procedure of self-management.
Therefore, this study aimed to develop and validate a procedure for self-management of medication
whilst in hospital, also named the SelfMED procedure.
2. Materials and Methods
During the first stage of this study a procedure for self-management of medication was developed.
During the second stage, it was validated with the involvement of several healthcare providers and a
multidisciplinary expert meeting. Questions in the assessment that could be biased by the opinion
of nurses were tested for inter-rater reliability. The study was conducted in accordance with the
Declaration of Helsinki, approval of the ethics committee of the general hospital Klina was provided
on 19 November 2015, reference number 031/200/015.
2.1. Stage 1: Development of Procedure
During the first stage of developing the SelfMED procedure several actions were undertaken.
As shown in Figure S1, a previously conducted qualitative study on the perspectives of patients,
nurses, physicians, and hospital pharmacists concerning the strengths, weaknesses, opportunities,
and threats of self-management of medication during hospitalization was used. Study results
indicated both healthcare providers and patients stated important prerequisites in order to facilitate
self-management of medication in hospital. Analysis of these results allowed the authors to allocate
these prerequisites to three major topics; prerequisites related to the patient, the medication, and the
organization. Those related to the patient were; i.e., patients had to be self-managing medication
at home before hospitalization, they had to be willing to self-manage medication, and had to be
able—mentally and physically—to self-manage medication. Those related to the medication were;
i.e., self-managed medication should not consist of to many different types of medication. Those
related to the organization were; i.e., provide a clear legal context with defined responsibilities
in case of self-management, and a system to monitor medication self-management [9]. Secondly,
literature on medication adherence and validated tools to assess patient’s competencies to self-manage
were supplementary examined and compared to the findings of the qualitative research. Also,
the Morisky Medication Adherence Scale was consulted [8–10,12]. Thirdly, it was important to
adhere current regulation concerning medication self-management in Belgian hospitals. Therefore,
the Care inspection of the Flemish division of Wellbeing, Public Health, and Family was consulted.
Self-management of medication is allowed in hospitals if the self-managed medication is registered
in the patient’s personal medical file. During this process, healthcare providers maintain their duty
of care and their duty of surveillance, while the treating physician takes responsibility for allowing
and evaluating self-management of medication (Care inspection of the Flemish division of Wellbeing,
Public Health, and Family, personal communication, October 2015). Because of the current regulation
on self-management, the developed SelfMED procedure clearly stated self-managed medication had to
be noted down in the patient’s medical file. Also, the SelfMED monitoring tool—a part of the SelfMED
procedure—facilitated the duty of surveillance and care, and the overall evaluation of self-management.
In the end, the described role of treating physician in the procedure indicated he/she has the final
decision on allowing or declining self-management and the type of self-managed medication.
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2.2. Stage 2: Validation
The first draft of the SelfMED procedure was validated in several phases (see Figure S1), by three
pharmacists, a physician, and a nurse manager who were employed in both university and regional
hospitals. They were selected based on their knowledge of hospital medication management, tool
development, and their role in direct patient care.
The first draft was evaluated on clarity, appropriateness, and face validity. Face validity measured
the degree to which the included questions measured what they were supposed to [13,14]. Also, the
clarity and wording were evaluated during this process. In addition, the healthcare providers assessed
the importance attached to the content of the questions and the appropriateness of the response scale
used. The format and the overall presentation of the SelfMED procedure was evaluated. After the
evaluation, adjustments were made based on the feedback; fewer answer categories were provided and
questions were reformulated in order to avoid jargon in the patient’s self-assessment. The monitoring
tool for self-managed medication was adjusted in order to make it easier to use and a clear description
was provided to support completing the form correctly.
The second draft of the SelfMED procedure was discussed in a multidisciplinary expert meeting.
The expert meeting consisted of nurses (n = 3), a nurse manager (n = 1), physicians (n = 2), and a
hospital pharmacist (n = 1) from a regional hospital. They were selected based on their knowledge on
hospital medication management in daily practice, as stakeholders who would use the procedure in
daily practice. Again, a revision for clarity, appropriateness, and the format and overall presentation
was conducted. Some minor alterations were made after this expert meeting; the lay-out was simplified
and adjusted in order to facilitate the use of a paper-based SelfMED procedure, the actual number of
days a patient needed to be hospitalized in order to assess his/her ability to self-manage was deleted,
the order of the first two statements of the nurse assessment was changed, the provided description on
how to use the monitoring tool was rewritten more concisely.
A part of the SelfMED procedure consisted of an assessment that questioned the opinion of a
nurse on the capabilities of hospitalized patients to self-manage their medication. Three statements
concerned the mental and physical state of the patient, and one the capability to deal with changes
in the medication regimen. As these questions may be biased by the nurse assessing the patient, two
nurses independently assessed patients.
2.3. Study Methodology
The study on evaluating bias took place in a regional hospital, on a cardiology ward specialized
in heart failure, cardio revalidation, and postinterventional care. Two nurses agreed on assessing
the patients, both nurses were working on the participating ward. All consecutive patients on the
ward were eligible to participate if over the age of 18 years old. All subjects received oral and
written information about the study and who—with the use of the nurse’s assessment—assessed their
competence for self-management of medication in hospital. Also, the nurse’s assessment evaluated
whether patients had to be taking medication in hospital, if not they could not participate the study.
All patients gave their informed consent for inclusion before they participated in the study. Data
collection was performed from February until March 2016. During the completion of the assessment
there was no contact between the assessing nurses. Both conducted their assessment one after the
other, in order to rule out possible changes in the health status of the patients. Afterwards the
inter-rater reliability was calculated by the Cohen’s Kappa, this resulted in the percentage agreement
between both nurses [15–18]. The Statistical Package for Social Sciences (SPSS) version 24.0 (SPSS Inc.,
Chicago, IL, USA) was used to analyze the data. Discontinuous data were described using frequency
distributions. Continuous data were described using a mean value and standard deviation if normally
distributed or using a median and range if non-normally distributed. A p value of 0.05 was considered
as statistically significant.
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2.4. Translation
For publication purposes a forward-translation from the Dutch version of the SelfMED procedure
to English was performed. Two translators independently performed their translations, one translator
was a native English speaker the other was perfect bilingual. None of them were previously involved in
this study, yet they did have knowledge concerning medication management, healthcare, and hospital
care. After translating, both translators discussed their translations and resolved some differences.
Then, the English version of the SelfMED procedure was back-translated by an independent translator
with an academic background and a level five (C1) in English concerning the Common European
Framework of Reference. This translator was bilingual and has not been involved in this, nor previous
studies concerning this topic. Back-translation revealed some minor unclear wordings; these were
adapted in the English version [16].
3. Results
3.1. Stage 1: Development
The SelfMED procedure in this study was developed through several stages (see Figure S1). As a
result of this process, the SelfMED procedure consists of several phases, each described in following
sections (see Figure S2). The complete SelfMED procedure can be consulted in Figure S3.
3.1.1. Nurse Assessment
A ten-statement assessment allows the nurse to assess the eligibility of the patients for
self-management of medication. Filling out this assessment can be done based on the information
which is obtained during the intake and information available in the patient’s medical file. Nurses
are able to define an answer to the statement in the first column (agree/not agree/not known) and
assess whether the statements are a barrier for self-management in the second column (barrier for
self-management/possible barrier for self-management/no barrier for self-management). At the end
of the assessment the nurse indicates whether the patient is eligible for self-management, if so the
patient needs to further fill out the patient self-assessment.
3.1.2. Patient Self-Assessment
If the nurse deems the patient capable of self-managing medications, the next phase of the
procedure consists of a patient questionnaire. The patient should complete this self-assessment on
their own. The questions in the assessment consist of: the current medication management at home
(one item), the patient’s willingness to self-manage medication in hospital (one item), a possible need
for aide while self-managing in hospital (one item), and the patient’s therapy adherence out of hospital
(seven items). If a patient indicates he/she is not self-managing medication at home or is not willing to
self-manage medication, he/she does not have to complete the questionnaire.
The information from both the nurse’s assessment and the self-assessment enables nurses to
formulate advice for the treating physician to allow or decline self-management of medication.
If patients are willing to self-manage medication, nurses can further interpret the results of the
resulting questions concerning the patient’s medication management at home and their medication
adherence. Because of the active involvement of the patient during the assessment, it is possible to
also test the patient’s fine motor skills. These skills are of great importance in, for example, opening
medication blisters or checking off the medication list of self-managed medication.
If the nurse formulates negative advice, there is a possibility to advise a reassessment
at another moment in time. Improvement in health status can result in improvements in
self-management competence.
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3.1.3. Physician Assessment
In the next phase, the patient’s physician can make a final decision on allowing the patient to
self-manage medication. The advice formulated by the nurse, the nurse’s assessment, and the patient’s
self-assessment are available to make an informed decision. If the treating physician decides it is
not allowed to self-manage medication, there was a possibility to re-assess the patient at another
moment in time. If a patient is judged to be eligible and self-management is allowed, the actual
self-managed medicines need to be specified by the treating physician and registered in the patient’s
personal medical file. A clinical pharmacist can be involved to provide supplementary comments if
they are involved in the medication process.
3.1.4. Practical Issues for Starting Self-Management of Medication
If a patient is capable of self-managing medication, several practical arrangements have to be
made: provide the patient with a medication list on his medication, provide correct medication to the
patient room, and document the self-managed medication in the patient’s medical file. Also, patients
need to be educated on the monitoring system.
3.1.5. Monitoring Self-Management of Medication
Self-managing patients are instructed on the use of the monitoring tool. They are aware of the type
of medication, the time when to take medication, and the dosage. If the self-managed medication has
been taken, patients are asked to check off these medicines on the hour of intake on their medication
list. On a daily basis—during medication administration tours—the list with self-managed medication
has to be checked for mistakes by the nurse. If problems concerning medication self-management
occur, there is doubt about medication intake, or for research purposes, a pill count can be provided
optionally in order to detect medication errors.
The monitoring tool consists of a first column to define the date and the second shows the initials
of the monitoring nurses that day. The third and fourth column questions whether the patient is still
capable to self-manage medication, if not the reason should be formulated (i.e., sudden illness, mental
decline). If the status of the patient has not changed and he/she was self-managing medication, the
medication list is then evaluated and a pill count is optionally performed. The results should be noted
in the monitoring file on the patient’s room. If the patient succeeds in every aspect of self-management,
self-management can be continued. If patients fail in self-managing their medication, the nurse can
intervene by providing patient education to prevent this error from occurring again. If the errors in the
self-management are found to be problematic, it is possible to stop self-management. In case a patient
is not capable of self-managing medication, self-management stops. A possibility to reassess over a
period of time is provided.
3.2. Stage 2: Validation
Question four, five, and seven in the nurse’s assessment may be biased by the rater (see section
Nurse assessment Figure S3). Therefore, the kappa statistic was used to test inter-rater reliability [14].
A total of 158 hospitalized patients were assessed by two raters. Table 1 gave an insight in the
demographics of the assessed patient population. Only, if the assessing nurse deemed patients capable,
they completed the self-assessment. Therefore, only data from these patients on the level of education,
chronic medication intake at home, and self-management of medication during previous admissions
were collected and showed in Table 1. As shown in Table 2 all three questions had moderate to strong
levels of agreement between both raters (n = 158, question 4 κ 0.892, question 5 κ 0.843, question 7 κ
0.784; p < 0.001).
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Table 1. Demographics.
Patient Characteristics n %










Chronic medication intake at home (mean [range]) 71 4.7 [0–15]
Self-management of medication during previous admissions 74
Yes 74.3
No 25.7
Table 2. The inter-rater reliability of three question from the nurse’s assessment.
Opinion Nurse 2 (n)
Not agree Agree Unknown Kappa p value
Opinion nurse 2 (n)
The patient is physically
able to self-manage his
medication (n = 159)
Not agree 33 0 0
0.892 < 0.001Agree 6 120 0
Unknown 0 0 0
The patient is mentally able
to self-manage his
medication (n = 159)
Not agree 46 1 0
0.843 < 0.001Agree 10 102 0
Unknown 0 0 0
The expectation is that the
patient can handle possible
treatment changes (n = 159)
Not agree 47 3 0
0.784 < 0.001Agree 10 96 0
Unknown 3 0 0
4. Discussion
In this study the SelfMED procedure was developed. This procedure guides and supports patients
and healthcare providers during the decision-making process concerning allowing or declining
self-management and during actual self-management of medication. During the development,
the opinion of, not only nurses and patients, but also hospital pharmacists and physicians and
the current regulation on self-management in hospitals were taken into account. Therefore, all these
important stakeholders were included in the procedure.
The SelfMED procedure consists of a stepped assessment performed by the nurse (1), the patient
(2), and the hospital pharmacist and treating physician (3). This assessment enables the treating
physician to provide a well-informed decision on allowing or declining a patient to self-manage
medication in hospital. If a patient is allowed, the SelfMED monitoring tool will monitor the intake of
self-managed medication and detect possible medication errors or other medication related problems.
If problems occur, the SelfMED procedure encourages interventions such as patient education to
provide them from reoccurring. The procedure distinguishes itself from previously developed tools,
as it includes all important stakeholders and adheres to current regulation. Furthermore, it not
only assesses patient’s competencies but also guides and supports monitoring self-management and
encourages healthcare providers to improve the patient’s self-management skills if necessary [6,7,10].
Pharmacy 2018, 6, 77 8 of 11
The role of hospital pharmacists was briefly described in the assessment phase. Nevertheless,
their involvement is foremost important. As described in literature, the active involvement of
hospital pharmacists on clinical wards resulted in several benefits such as improved care and reduced
harm [19]. Specifically, for self-management of medication in hospital, hospital pharmacists can
provide counseling sessions for patients when problems arise concerning adherence that occurs during
self-management, and they can support nurses in educating patients on medication. Also, pharmacists
can clarify discharge prescriptions, as literature indicated this as a problem for patients [20]. Research
on hospital pharmacists providing patient counseling before hospital discharge and telephone follow
up after discharge indicated a significant association with less adverse drug events [21]. These findings
strengthen the hospital pharmacists’ important role.
4.1. The SelfMED Procedure in Daily Practice
Previous literature on self-management of medication indicated possible advantages such
as; increased patient satisfaction, increased patient safety, an improvement of adherence to
pharmacotherapy, and self-care competence [5,6,9,22]. Research on the willingness of patients
highlighted they were generally very willing to self-manage medication in hospital. Nevertheless,
if patients do not want to self-manage medication this should be respected [22].
Notwithstanding the possible advantages of self-management of medication, actually
implementing the SelfMED procedure requires some changes in the current medication management
process. Compared to nurses preparing and administering medication, self-management implicates
patients have to be assessed first to determine their competence for self-management. Additionally,
self-managed medication is ideally supplied as unit dose and logistics on how to transport medication
to the patient room and store it should be apparent. Previous research already provided a flowchart
on these advised adaptations [9]. Secondly, problems on medication shortages might influence the
delivery of self-managed medication, as the medicines might not be in stock [23].
Also, adaptations on ward-level are advisable. As stated in the procedure, the storage of
self-managed medication in closed lockers or the patient’s personal locker is advised. It is possible
not all patient rooms have access to a personal locker. Nevertheless, nightstands mostly tend to have
a build in locker. Also, when self-managing patients check off their medication list, as stated in the
SelfMED procedure, nurses are not possible to observe this other than checking the actual medication
list on the patient’s room. It would be an added value if this medication list could be provided on a
tablet or linked to an electronic patient data management system. Additionally, this can also provide
nurses with an overview on self-managed and nurse administered medication.
4.2. Implications for Research
The SelfMED procedure developed and validated in this study provides a first evidence-based
guide for self-management of medication. In order to refine and provide further improvements,
following implications for research were discussed.
The current SelfMED assessment comprised a stepped approach with a limited amount of
questions for nurses, patients, and physicians. It is expected that due to this approach the time
investment for completing the assessment remains limited for each stakeholder. Supplementary
research on the effect of self-management on time management of involved stakeholders is advised.
Because of the possible bias in three questions from the nurse assessment, inter-rater reliability
was calculated. Yet, in future research the inter-rater reliability of the complete SelfMED assessment
should be determined, since the opinion of physicians can be a subject to bias and bias in other
questions from the nurse assessment could be present.
When patients are found to be capable to self-manage, the nurse formulates a positive advice
for the treating physician. It is expected nurses are adequately educated and have sufficient clinical
judgment to assess a patient with the use of a checklist already providing all important topics. By
providing these topics, reproducibility can be increased. The final decision on self-management
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can be taken by the physician. As this healthcare provider remains responsible for medication
during hospital admission, the physician will be able to define which medicines can be self-managed.
Previous qualitative research indicated physicians are more likely to prohibit patients to self-manage
high-risk medication. Nevertheless, this viewpoint can be discussed and should be investigated further,
for example transplant patients self-manage their medication in order to be able to manage them
correctly after discharge. Allowing patients to already self-manage high-risk medication in a controlled
environment might ultimately result in a benefit for the patient [9]. Literature on the treatment of
diabetes in hospital even encouraged patients to self-manage their insulin when hospitalized on the
condition that this is also monitored by healthcare providers [24,25].
The current SelfMED monitoring tool provides an evaluation of medication self-management.
If medication errors occur, the flowchart suggests healthcare providers to educate patients in order to
prohibit the error from reoccurring. As this is a crucial step towards improving the self-management
skills and possible medication knowledge further research should focus on expanding this aspect of
the SelfMED procedure [26].
Previous literature on the effect of self-management of medication indicated several positive
results. Nevertheless, these results should be taken into account cautiously due to methodological flaws
and low-quality research [6,7]. Future research should therefore focus on the effect of self-management
of medication on patient outcomes (patients satisfaction, medication errors during hospitalization,
influence on therapy adherence after discharge, and patient self-management skills after discharge), the
influence on quality of care, medication management processes, and influence on the healthcare costs.
The current SelfMED procedure was developed focusing on the average hospitalized patient on
a cardiology ward. Therefore, it is important when using this procedure in a specific population, in
example geriatric or psychiatric patients, adaptations in the assessment criteria might be needed in
order to meet the aim of correctly assessing patients and supporting self-management of medication.
5. Conclusions
The SelfMED procedure developed and validated in this study has the potential to guide
and support self-management of medication in hospital. Because of the inclusion of all important
stakeholders within the medication management process, the evidence-based approach and the
fit with current regulation the procedure distinguishes itself from previously described tools.
Further refinements and validation in daily practice are advised, also a tool for providing tailor
made interventions for medication related problems during self-management should be developed
and validated.
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